Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morgen-Walke Associates was a leading investor relations and strategic communications firm that played a pivotal role in the growth of the biotechnology and healthcare sectors during the 1990s. The firm specialized in providing financial public relations, crisis management, and investor targeting services to emerging growth companies, particularly in life sciences and technology. At its peak, it was one of the largest independent investor relations agencies in the United States, representing hundreds of public and private entities. The company was known for its deep expertise in navigating the complexities of Wall Street and the medical regulatory environment. In 2000, the firm was acquired by Lighthouse Communications, which was subsequently integrated into larger global marketing networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morgen-Walke Associates.